NIPPON SHINYAKU
Nippon Shinyaku is a manufactures pharmaceutical and health food products.The Company produces drugs for urinary, nerve, respiratory, and circulatory systems as well as analgesic and anti-inflammatory drugs. Nippon Shinyaku also develops synthetic anti-bacterial agents.
NIPPON SHINYAKU
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
1919-09-23
Status:
Active
Contact:
81-75-321-1111
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Nginx Microsoft Exchange Online
Similar Organizations
Health Seven Dimensional
Health Seven Dimensional is the manufacturer of pharmaceutical and medical device products.
Korean Drug
Korean Drug manufactures pharmaceutical and health care products.
Nissui Pharmaceutical
Nissui Pharmaceutical manufactures and sells pharmaceuticals and health foods for pharmacies.
Zim Laboratories
Zim Laboratories is a manufacturer of pharmaceutical products.
Founder
Stock Details
More informations about "Nippon Shinyaku"
A new way of life | NIPPON SHINYAKU CO., LTD.
We believe that helping society and local communities to develop and thrive constitutes one of …See details»
Company Information/Company Profile │ Who we are │ NIPPON …
Nippon Shinyaku Co., Ltd. Business lines: Manufacture and sale of pharmaceuticals and …See details»
A New Way of Life - nippon-shinyaku.co.jp
Nippon Shinyaku aims to contribute to creating healthy and fulfilling lives through two …See details»
Vicore and Nippon Shinyaku Enter into an Exclusive
Feb 9, 2024 · Vicore is eligible to receive tiered royalties extending into the low 20s based on annual net sales of C21 in Japan. Nippon Shinyaku holds the exclusive right to develop and commercialize C21 in Japan focusing initially on …See details»
Nippon Shinyaku - Crunchbase Investor Profile & Investments
Nippon Shinyaku is a manufactures pharmaceutical and health foods products. View contacts …See details»
Nippon Shinyaku and Atsena Therapeutics enter into an Exclusive ...
Nov 13, 2024 · Based on Nippon Shinyaku’s business philosophy, “Helping people lead …See details»
Pipeline Developments - NS Pharma
NS Pharma, Inc. has been developing NS-229 (for Eosinophilic granulomatosis with …See details»
MiNA Therapeutics Enters Research Collaboration with Nippon …
Based on Nippon Shinyaku’s business philosophy, “Helping people lead healthier, happier …See details»
Capricor Therapeutics and Nippon Shinyaku Enter …
Feb 16, 2023 · Based on Nippon Shinyaku’s business philosophy, “Helping people lead healthier, happier lives,” we aim to be an organization trusted by the community through creating unique medicines that will bring hope to patients …See details»
R&D Organization │ R&D │ NIPPON SHINYAKU CO., …
Nippon shinyaku maintain a venture-like organizational structure and aim for distinctive drug development in small molecule drugs and nucleic acid drugs, as well as gene therapy as a new modality. We introduce useful technologies …See details»
Nippon Shinyaku : Announcement of Alliance Agreement for …
Mar 25, 2024 · In signing the alliance agreement, as Nippon Shinyaku offers several …See details»
Nippon Shinyaku CO., LTD. – Annual Report | UN Global Compact
Jan 7, 2022 · Annual Report Participant. Nippon Shinyaku CO., LTD. Published. 07-Jan-2022 …See details»
Vicore and Nippon Shinyaku Enter into an Exclusive License …
Vicore is eligible to receive tiered royalties extending into the low 20s based on annual net …See details»
Nippon Shinyaku and Capricor Therapeutics Enter into an Exclusive ...
Jan 25, 2022 · Nippon Shinyaku Co., Ltd. (Headquarters: Kyoto, Japan, President: Toru Nakai) …See details»
Capricor Therapeutics Signs Binding Term Sheet with Nippon …
Sep 17, 2024 · Based on Nippon Shinyaku’s business philosophy, “Helping people lead …See details»
Creating various person - nippon-shinyaku.co.jp
Nippon Shinyaku aims to contribute to creating healthy and fulfilling lives through two …See details»
EC Grants Orphan Drug Designation to viltolarsen (NS-065/NCNP …
Kyoto, Japan, June 8, 2020 – Nippon Shinyaku Co., LTD. (Nippon Shinyaku; Kyoto; President, …See details»
Atsena Licenses LCA1 Gene Therapy Candidate to Nippon …
1 day ago · Atsena Therapeutics announced Nov. 13 that it had granted exclusive commercial …See details»
Developing Diverse Human Resources and Realizing Employee …
At Nippon Shinyaku, we strive to “promote human capital management that allows each …See details»
The End of Tradition? Adaptation and Abandonment of Festivals in …
1 day ago · These issues have made leadership, organization, and the passing down of …See details»